Enbrel® in Psoriatic Arthritis

This study is testing the effect of etanercept in treating both

the skin and joint symptoms of psoriatic arthritis patients. Enbrel®, also

known as etanercept, has already been approved by the Federal Food Drug

Administration for the treatment of psoriatic arthritis. It is taken as an

injection under the skin. Participants in the trial will be offered etanercept free of charge to be

self-injected once weekly for 24 weeks. During that period they

will have 5 appointments at the study center and will also be asked to

complete assessments of their health.